Phibro Animal Health
PAHC • NASDAQ
Phibro Animal Health is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Jack Clifford Bendheim, with a market cap of $2.2B.
Market Cap$2.2B
Employees1.9K
CEOJack Clifford Bendheim
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 6, 2026 · In 2 weeksAfter Market Close · Q3 2026
Financials
Phibro Animal Health FAQ
Common questions about Phibro Animal Health
Phibro Animal Health is scheduled to report earnings for Q3 2026 on May 6, 2026 after market close. Analysts estimate revenue of $363.5M.
Phibro Animal Health has approximately 1,920 employees.